Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
- 1Rheumatology Unit, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 2Neuroimmunology Unit, Department of Clinical Neurosciences, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
- 3Science for Life Laboratory, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
- 4Translational Research program, BRI at Virginia Mason, Seattle, WA, USA
- 5Tetramer Core, BRI at Virginia Mason, Seattle, WA, USA
- 6Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
- 7Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- 8Science for Life Laboratory, Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden
- 9Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden
A corrigendum on
The original version of this article contained a typographical error in the spelling of the author Karolina Tandre, which was incorrectly given as Carolina Tandre. The authors apologize for the mistake. This error does not change the scientific conclusions of the article in any way.
The original article was updated.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Keywords: rheumatoid arthritis, HLA-DR4/α-enolase, neo-antigen, CD4+ T cell, autoimmunity, cytokines, crystal structures
Citation: Gerstner C, Dubnovitsky A, Sandin C, Kozhukh G, Uchtenhagen H, James EA, Rönnelid J, Ytterberg AJ, Pieper J, Reed E, Tandre K, Rieck M, Zubarev RA, Rönnblom L, Sandalova T, Buckner JH, Achour A and Malmström V (2017) Corrigendum: Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis. Front. Immunol. 8:1236. doi: 10.3389/fimmu.2017.01236
Received: 13 September 2017; Accepted: 19 September 2017;
Published: 04 October 2017
Edited and Reviewed by: Rene De Waal Malefyt, Merck Research Laboratories, Palo Alto, United States
Copyright: © 2017 Gerstner, Dubnovitsky, Sandin, Kozhukh, Uchtenhagen, James, Rönnelid, Ytterberg, Pieper, Reed, Tandre, Rieck, Zubarev, Rönnblom, Sandalova, Buckner, Achour and Malmström. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Christina Gerstner, Y2hyaXN0aW5hLmdlcnN0bmVyJiN4MDAwNDA7a2kuc2U=
†These authors have contributed equally to this work.
‡Shared last authors.